BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17217945)

  • 1. Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors.
    Wise LE; Shelton CC; Cravatt BF; Martin BR; Lichtman AH
    Eur J Pharmacol; 2007 Feb; 557(1):44-8. PubMed ID: 17217945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
    Haller VL; Stevens DL; Welch SP
    Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice.
    Wiley JL; Razdan RK; Martin BR
    Life Sci; 2006 Dec; 80(1):24-35. PubMed ID: 16978656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase.
    Pacher P; Bátkai S; Osei-Hyiaman D; Offertáler L; Liu J; Harvey-White J; Brassai A; Járai Z; Cravatt BF; Kunos G
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H533-41. PubMed ID: 15821037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
    Varvel SA; Wise LE; Niyuhire F; Cravatt BF; Lichtman AH
    Neuropsychopharmacology; 2007 May; 32(5):1032-41. PubMed ID: 17047668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anandamide effects on 5-HT(3) receptors in vivo.
    Rácz I; Bilkei-Gorzo A; Markert A; Stamer F; Göthert M; Zimmer A
    Eur J Pharmacol; 2008 Oct; 596(1-3):98-101. PubMed ID: 18775693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
    Lichtman AH; Hawkins EG; Griffin G; Cravatt BF
    J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.
    Lichtman AH; Shelton CC; Advani T; Cravatt BF
    Pain; 2004 Jun; 109(3):319-327. PubMed ID: 15157693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse.
    Palmer JA; Higuera ES; Chang L; Chaplan SR
    Neuroscience; 2008 Jul; 154(4):1554-61. PubMed ID: 18541380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.
    Cravatt BF; Demarest K; Patricelli MP; Bracey MH; Giang DK; Martin BR; Lichtman AH
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9371-6. PubMed ID: 11470906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M; Medalie J; Fratta W; Vadivel SK; Makriyannis A; Piomelli D; Mikics E; Haller J; Yasar S; Tanda G; Goldberg SR
    Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation.
    Habayeb OM; Taylor AH; Bell SC; Taylor DJ; Konje JC
    Endocrinology; 2008 Oct; 149(10):5052-60. PubMed ID: 18599552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization.
    Thiemann G; van der Stelt M; Petrosino S; Molleman A; Di Marzo V; Hasenöhrl RU
    Behav Brain Res; 2008 Mar; 187(2):289-96. PubMed ID: 17988751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.
    Ortega-Gutiérrez S; Hawkins EG; Viso A; López-Rodríguez ML; Cravatt BF
    Biochemistry; 2004 Jun; 43(25):8184-90. PubMed ID: 15209515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP; Paola Piras A; D'Agostino A; Pibiri F; Perra S; Gessa GL; Maccarrone M; Pistis M
    Eur J Pharmacol; 2007 Nov; 573(1-3):11-9. PubMed ID: 17644084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
    Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
    J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task.
    Varvel SA; Cravatt BF; Engram AE; Lichtman AH
    J Pharmacol Exp Ther; 2006 Apr; 317(1):251-7. PubMed ID: 16352706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint.
    Lam FF; Luk PW; Ng ES
    Life Sci; 2007 Mar; 80(16):1495-502. PubMed ID: 17275857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
    J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.